Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Event Details

Filter
WorldConference

International Conference on Obesity and Chronic Diseases

International Conference on Obesity and Chronic Diseases

Add this event to your calendar: iCal   Google Calendar

Who should attend?

doctors researchers dietitians healthcare professionals bariatric surgeons

Details

ME Conferences welcomes Attendees, Presenters, and Exhibitors from all over the world to participate at the International Conference on Obesity and Chronic Diseases going to be held onOctober15-16,2018 in Dubai, UAE. Main Focus and Theme of the conference is “Prevention and Advanced Treatment procedures for Obesity and Chronic Diseases”.

Chronic Obesity 2018 is a Worldwide stage to Examine and find out about Weight Management, Genetics of obesity, Anti-obesity drugs, Obesity &Cancer,  Obesity in women, Obesity and Cardiovascular disorders, Obesity and Diabetes, Advanced Medications for Obesity and many Chronic Diseases like Cancer ,Asthma ,Kidney Diseases Scientific gatherings and Meetings in the field of Obesity.

We are sure that the International Conference on OBESITY AND CHRONIC DISEASE2018 will be a unique chance for High quality scientific program with Session lectures, Symposia, Workshops, Poster Presentations and completely different Programs for Participants from throughout the Globe

Prices

on before april 23 650euros on before july 22 750 euros on before october 15 860 euros

Contact

Zara Alexa
Zaraalexa9@gmail.com

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.